Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$30.04 - $51.31 $387,516 - $661,899
-12,900 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$27.44 - $73.84 $340,887 - $917,314
12,423 Added 2604.4%
12,900 $407,000
Q4 2019

Feb 14, 2020

SELL
$35.4 - $59.82 $49,984 - $84,465
-1,412 Reduced 74.75%
477 $28,000
Q3 2019

Nov 14, 2019

BUY
$34.47 - $47.53 $24,990 - $34,459
725 Added 62.29%
1,889 $69,000
Q2 2019

Aug 14, 2019

BUY
$40.1 - $52.33 $46,676 - $60,912
1,164 New
1,164 $54,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $120M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.